Goldman Sachs’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Goldman Sachs’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-29,402	Closed	-$185K	–	6880
2013 Q2	$185K	Buy	+29,402	New	+$176K	﹤0.01%	5640

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Goldman Sachs's PBTH Position: Q3 2013 in Review

Goldman Sachs sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 29,402 shares — an estimated $185K sold.

Goldman Sachs first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $185K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Goldman Sachs reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Goldman Sachs sold 29,402 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $185K.
Goldman Sachs first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Goldman Sachs's PROLOR Biotech, Inc. Common Stock position peaked at $185K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Goldman Sachs's 13F filing for Q3 2013, filed 14 Nov 2013.